We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow %
92.95%
Top 10 Hldgs %
42.01%
Holding
143
New
143
Increased
–
Reduced
–
Closed
–

Top Buys

1
HUM icon
Humana
HUM
+$10.2M
2
DVA icon
DaVita
DVA
+$6.77M
3
UNH icon
UnitedHealth
UNH
+$6.72M
4
PNTG icon
Pennant Group
PNTG
+$5.2M
5
CAH icon
Cardinal Health
CAH
+$3.95M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 67.79%
2 Financials 23.65%
3 Energy 1.95%
4 Materials 1.84%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FFBC icon
76
First Financial Bancorp
FFBC
$3.75B
$348K 0.29%
+12,422
New +$339K
EQX icon
77
Equinox Gold
EQX
$6.8B
$346K 0.29%
+57,072
New +$319K
QTTB icon
78
PUT
Q32 Bio
QTTB
$255M
$344K 0.29%
+105
New +$3.32K
SLNO
79
CALL
DELISTED
Soleno Therapeutics
SLNO
$329K 0.27%
+556
New +$28.8K
MYFW icon
80
First Western Financial
MYFW
$323M
$307K 0.25%
+14,538
New +$297K
RVPH
81
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$305K 0.25%
+8,059
New +$224K
ARQT icon
82
Arcutis Biotherapeutics
ARQT
$3.56B
$302K 0.25%
+22,810
New +$250K
CLYM
83
Climb Bio
CLYM
$727M
$277K 0.23%
+145,760
New +$527K
EOLS icon
84
Evolus
EOLS
$377M
$266K 0.22%
+19,054
New +$268K
BBIO icon
85
CALL
BridgeBio Pharma
BBIO
$15.9B
$260K 0.22%
+572
New +$14.8K
ETNB
86
DELISTED
89bio
ETNB
$258K 0.21%
+26,842
New +$221K
VIR icon
87
Vir Biotechnology
VIR
$1.59B
$250K 0.21%
+24,069
New +$190K
ESQ icon
88
Esquire Financial Holdings
ESQ
$1.06B
$250K 0.21%
+2,797
New +$201K
HALO icon
89
CALL
Halozyme
HALO
$9.23B
$238K 0.2%
+303
New +$15.5K
SPY icon
90
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$225K 0.19%
+527
New +$310K
RARE icon
91
PUT
Ultragenyx Pharmaceutical
RARE
$2.88B
$174K 0.14%
+320
New +$15.9K
RXRX icon
92
CALL
Recursion Pharmaceuticals
RXRX
$1.56B
$168K 0.14%
+906
New +$6.09K
RKT icon
93
Rocket Companies
RKT
$41.1B
$157K 0.13%
+12,426
New +$185K
KRE icon
94
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.97B
$150K 0.12%
+622
New +$38.6K
NKTR icon
95
Nektar Therapeutics
NKTR
$2.31B
$138K 0.11%
+11,105
New +$196K
SLSR
96
Solaris Resources
SLSR
$1.18B
$134K 0.11%
+41,812
New +$113K
AGIO icon
97
CALL
Agios Pharmaceuticals
AGIO
$2.36B
$133K 0.11%
+310
New +$14.6K
SLNO
98
PUT
DELISTED
Soleno Therapeutics
SLNO
$130K 0.11%
+318
New +$16.5K
CAPR icon
99
CALL
Capricor Therapeutics
CAPR
$1.13B
$115K 0.1%
+605
New +$10.6K
ALT icon
100
CALL
Altimmune
ALT
$558M
$110K 0.09%
+602
New +$4.6K
2 3
4
5 6

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Persistent Asset Partners, which disclosed 143 positions worth $121M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Humana: 38,160 shares worth $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, followed by Financials and Energy.

  • Persistent Asset Partners's largest Q4 2024 buy was Humana: 38,160 shares worth $11.2M.
  • Persistent Asset Partners's ten largest holdings make up 42% of its $121M portfolio in Q4 2024.
  • Persistent Asset Partners disclosed 143 positions in Q4 2024, its first 13F filing on record.

Based on Persistent Asset Partners's 13F filing for Q4 2024, filed 14 Feb 2025.